Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a specified four-component **intravenous balanced crystalloid electrolyte combination** comprising sodium acetate anhydrous, sodium chloride, potassium chloride, and magnesium chloride. It is intended to restore extracellular fluid volume and replenish sodium, potassium, magnesium, chloride, and acetate ions; acetate is metabolized to bicarbonate equivalents and can support acid-base balance. The supplied component list does not uniquely identify a verified marketed formulation or strength. In particular, it should not be treated as synonymous with Normosol-R or Plasma-Lyte products, whose labeled formulations also contain sodium gluconate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium acetate anhydrous + sodium chloride + potassium chloride + magnesium chloride.